What is the latest status of the project “Insulet CR”?

The status recorded for “Insulet CR” is active.

What is the budget and commercial profile for the project “Insulet CR”?

Taiyo normalizes the budget of “Insulet CR” to USD 97000000.

Where can I verify the source and access all details for “Insulet CR”?

This Taiyo project page references International Finance Corporation (IFC) along with the original URL (https://disclosures.ifc.org/project-detail/SII/51930/insulet-cr). Taiyo standardizes official data into a consistent, searchable project profile.

Insulet CR

Sector: Manufacturing (Industrial) • Location: Costa Rica

Source: International Finance Corporation (IFC)

Project

Active

Insulet Corporation (Insulet or the Company) is a MedTech company specializing in diabetes management solutions. The Company is planning to establish its first manufacturing facility in Latin America, dedicated to the production of its flagship product, the Omnipod insulin management system, a tubeless insulin delivery device for people living with diabetes (the Project). The new manufacturing fac

Project Information

4 Q

The project “Insulet CR” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Costa Rica. Taiyo aggregates data on it from International Finance Corporation (IFC).

Want to explore the full details? View the full report

Participants

Sponsoring Agency	Obfuscated Data
Company	Obfuscated Data

Status

Original status	active
Taiyo status	Obfuscated Data
Taiyo last update	00-00-0000
Available timestamps	00-00-0000
Available timestamp type	Obfuscated Data

Contact

Contact name	Obfuscated Data
Phone	0000000000
Email	ObfuscatedData@email.com
Address	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description	Insulet Corporation (Insulet or the Company) is a MedTech company specializing in diabetes management solutions. The Company is planning to establish its first manufacturing facility in Latin America, dedicated to the production of its flagship product, the Omnipod insulin management system, a tubeless insulin delivery device for people living with diabetes (the Project). The new manufacturing facility will be located within Savia Sur, a light industrial park in Heredia, Costa Rica, developed by Portafolio Inmobiliario (Portafolio or the Developer). The proposed IFC investment consist of a US$97 million A Loan, to support the construction of the facility's coldshell. The Borrower will be 3-101-939148 SA (Savia SPV), a special purpose vehicle responsible for managing the assets of the industrial park where the plant will be located.
Original sub-sector	Obfuscated
Original Currency	USD
Original budget	000000000000000
Procurement method	Obfuscated Data
Budget	000000000000000

Location

Region	Obfuscated
Country	Obfuscated
State	Obfuscated Data
County	Obfuscated
Location	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability	High
Data quality score	100%
Source	Obfuscated Data
URL	obfuscated_data,obfuscateddata.com

More Details

Project Type	Obfuscated Data
Article Published Date	Obfuscated Data

Insulet CR

Project Information FAQ

Project Information